Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Selenium sulfide by Azura Ophthalmics for Meibomian Blepharitis: Likelihood of Approval
Selenium sulfide is under clinical development by Azura Ophthalmics and currently in Phase III for Meibomian Blepharitis. According to GlobalData,...
Data Insights
Selenium sulfide by Azura Ophthalmics for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval
Selenium sulfide is under clinical development by Azura Ophthalmics and currently in Phase III for Keratoconjunctivitis Sicca (Dry Eye). According...